Bridion 200 MG/2 ML vial 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FTD1D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,746
Award facts
- Contract value 100% obligated
- $21,746.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Bridion 200 mg/2 mL vials with a ceiling value of $21,746.30 and an ultimate completion date of January 13, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating full and open competition. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
Bridion (sugammadex) is a neuromuscular blocking agent reversal medication used in anesthesia to facilitate rapid recovery from neuromuscular blockade during surgical procedures. This delivery order reflects AmerisourceBergen's ongoing role as a critical pharmaceutical distributor supporting federal military and veteran healthcare systems through the DLA's pharmaceutical supply chain. The company's extensive portfolio of federal contract awards demonstrates its capability to efficiently fulfill government procurement requirements for specialized pharmaceutical products across multiple therapeutic domains, supporting military treatment facilities and other federal medical institutions globally.
Quick answers
Who was awarded contract SPE2DR26FTD1D?
SPE2DR26FTD1D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FTD1D worth?
The government has obligated $21,746 on SPE2DR26FTD1D.
Is contract SPE2DR26FTD1D an order under another contract?
Yes. SPE2DR26FTD1D is a delivery order under SPE2DR25D1113, an indefinite delivery contract.
Was contract SPE2DR26FTD1D competed?
The extent of competition for SPE2DR26FTD1D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award